3Mixtatin and MTA Vital Pulpotomy in Primary Molars (NCT06478940) | Clinical Trial Compass
Not Yet RecruitingPhase 1
3Mixtatin and MTA Vital Pulpotomy in Primary Molars
50 participantsStarted 2024-08-01
Plain-language summary
The aim of the study is to evaluate clinical and radiographic success of using 3Mixtain versus mineral trioxide aggregate in pulpotomy of deeply carious Primary molars.
Who can participate
Age range4 Years – 8 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Children 4-8 years old
* Vital deeply carious primary molars.
* No history of spontaneous pain, pathologic mobility, draining sinus tract, redness or swelling of the vestibule.
* Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test.
* Patient and parent showing cooperation and compliance.
Exclusion Criteria:
* • Uncooperative children to avoid time waste and attrition bias.
* Unrestorable molars
* Sign of radiolucency in periapical or furcation area
* Widening of PDL space or loss of lamina dura continuity
* Evidence of internal/external pathologic root resorption
* During operative procedure, when hemorrhage control is not achievable after pulpotomy.
* Children with systemic disease as some systemic diseases may have effect on the outcome.
* Unable to attend follow-up visits to avoid attrition bias by decreasing number of drop off cases.
* Refusal of participation as the parent of child has the authority of participation.